This is a demo store. No orders will be fulfilled.

Life Sciences

Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas

The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.

Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.

The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.

We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.

We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.

  1. 10 Mar 2017  |  Global

    Technologies for Cancer Research

    Cancer therapeutics are rapidly evolving with better targets and biologics. The greatest therapeutic current need is present across the indication of cancer. With each individual having a different and more unpredictable form of the disease, the need for personalized medicine is far greater. Hence, novel drug discovery technologies and drug deliver...

    $950.00
  2. This Industrial Bioprocessing TOE features trends and innovations in healthcare sector. The TOE edition focusses on various technology innovations based on prebiotic sugar substitutes and provides insights on the funding scenario. Corresponding patents are also provided along with industry interactions. This Industrial Bioprocessing TOE features t...

    $250.00
  3. This Genetic Technology TOE depicts trends across prebiotic and probiotic therapies for disorders of the gastrointestinal tract. The corresponding analysis of leading prebiotic and probiotic companies, and the analysis of Top 20 companies with OTC prebiotics and probiotics are depicted along with industry interactions. The Genetic Technology TechV...

    $250.00
  4. The latest issue of the Medical Devices TOE profiles eight innovations spanning the breadth of the MedTech space. These include innovations in the biosensors space, which enable non-invasive and non-contact vital signs monitoring, advanced wound care technologies, minimally-invasive surgical technologies, and innovative cell therapies for bone hea...

    $950.00
  5. 14 Feb 2017  |  North America

    Trends, Opportunities, and Future of the Global Pharma Extractables and Leachables Testing Market

    Growing Prominence of Single Use Technologies and Biologics Market Driving Growth

    This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...

    $1,500.00
  6. 02 Feb 2017  |  Europe

    European Next-generation Sequencing Services Market, Forecast to 2023

    Exome and RNA Sequencing Focusing on Applied Markets to Drive Growth

    The study aims to analyse the key disruptions transforming the next-generation sequencing (NGS) services market in Europe and profile regional markets with significant growth potential Research Scope: • Revenue Forecasts • Regional Market Dynamics • Market Share Analysis and Top Countries • Key Trends and Growth Opportunities • Game-chan...

    $4,950.00
  7. 24 Jan 2017  |  Asia Pacific

    Game-changing Strategies of APAC Pharma Companies

    Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

    $1,500.00
  8. 18 Jan 2017  |  North America

    Disruptive Technologies and Game-changing Companies in the Global Pharmaceutical Cell Banking Market

    Proprietary CMO Cell Culture Technology Platforms are Disrupting the In-house-outsourced Balance of Cell Banking Services

    This market insight on the global cell banking market analyses disruptive technologies and provides details on game-changing companies. Biopharmaceutical companies are increasingly partnering with CMOs and CROs to store their proprietary cell lines and develop new ones. With increased collaborations, CMOs are coming up with niche and specific servi...

    $1,500.00
  9. 17 Jan 2017  |  Europe

    Game-changing Strategies of European Pharma Companies

    Strong Focus on Digital Footprint and Beyond-the-pill Services Propel Companies to Innovate and Stay on the Growth Trajectory

    Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing European pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing. The study...

    $1,500.00
  10. 13 Jan 2017  |  North America

    Global Pharmaceutical Stability Testing Market Trends, Opportunities, and Future

    Consolidated Stability Storage is Leading to CROs Evolving into Development Partners and Driving the Stability Testing Outsourcing Market

    This research service on the global pharmaceutical stability testing market addresses market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year is 2015 and forecasts are provided from 2016 to 2020. The market is expected to grow at a CAGR of 9.4% till 2020, driven by an explosio...

    $1,500.00